RECURRENT ENDOMETRIAL SEROUS ADENOCARCINOMA
Clinical trials for RECURRENT ENDOMETRIAL SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ENDOMETRIAL SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT ENDOMETRIAL SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer-Fighting virus trial seeks to target tumors
Disease control OngoingThis early-stage trial is testing a modified virus designed to infect and kill cancer cells in patients with advanced or recurrent endometrial cancer. The main goal is to find a safe dose and understand the side effects. Some patients also receive an additional oral drug that may…
Matched conditions: RECURRENT ENDOMETRIAL SEROUS ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 04, 2026 03:51 UTC
-
New drug duo tested for Tough-to-Treat uterine cancer
Disease control OngoingThis study is testing whether two drugs, niraparib and dostarlimab, work better together to treat a specific type of uterine cancer that has returned or persisted after previous treatment. The trial aims to see if this combination can shrink tumors and control the disease. It is …
Matched conditions: RECURRENT ENDOMETRIAL SEROUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Casey Cosgrove • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Major trial tests new weapon against advanced uterine cancer
Disease control OngoingThis large, late-stage study is testing whether adding an immunotherapy drug called pembrolizumab to standard chemotherapy works better for treating advanced or recurrent endometrial cancer. It involves over 800 patients with stage III, IV, or returning cancer. The goal is to see…
Matched conditions: RECURRENT ENDOMETRIAL SEROUS ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC